Learn about ClinixSummary's live capabilities, how we stack up against other AI scribes, our cost trajectory, and why a native AI stack sets us apart.
ClinixSummary is not just an idea - it is already helping clinicians every day. Here is what we deliver now and what's planned next.
A comparison of leading AI medical scribe products and where ClinixSummary stands.
| Company | Target Customer | Integration Style | Notable Strengths | Pricing* | Sources |
|---|---|---|---|---|---|
| Nuance DAX Copilot | Enterprise / Health Systems | Deep EHR integration (Epic, MEDITECH) | Microsoft backing, ambient + generative AI, established enterprise relationships | ~$600/seat/mo (reported estimate) | |
| Abridge | Enterprise / Health Systems | Epic integration (first PAL partner) | Auditability, Epic-native integration, multi-language support | ~$2,500/seat/yr (reported estimate) | |
| Nabla Copilot | Self-serve & Enterprise | Browser extension, API | Freemium model, quick setup, strong UI/UX | Free (30/mo) -> $120/provider/mo | |
| ClinixSummary | Self-serve -> Clinics | Mobile apps, browser extension (planned), EHR push | Native fine-tuned AI, multi-specialty support, ICD-10 coding, most cost-effective | Starting at $19/mo |
*Pricing figures are reported estimates except where publicly listed; actual enterprise contracts may vary.
Approximate COGS trajectory for each investment scenario (Option A/B/C). Gross margins improve over time as we scale and build our own AI stack.
Note: COGS values are approximate and assume gross margin improvements of 40%->45% (A), 40%->50% (B), and 40%->55% (C) over 36 months.
A native, domain-specific AI stack offers lasting strategic advantages over wrapping generic APIs.
Domain-specific fine-tuning, custom evaluation frameworks and medical guardrails ensure accuracy and patient safety at inference time.
Full QMS integration, audit trails and traceability are required for CE/UKCA marking and future FDA pathways for software-as-a-medical-device.
Medical data sensitivity demands on-premise deployment options and complete control over data flows and retention policies.
Long-term unit economics improve dramatically versus perpetual API fees. Gross margins scale from ~40% to ~55%+ with our own inference.
Specialty modules, structured data capture and the path to an integrated EHR + diagnostic decision support require deep AI integration.
Explore our 36-month pre-seed roadmap with investment scenarios, milestones, and financial projections.
View 36-Month Roadmap